These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 31163013)

  • 41. Update from a 12-Year Nationwide Fungemia Surveillance: Increasing Intrinsic and Acquired Resistance Causes Concern.
    Astvad KMT; Johansen HK; Røder BL; Rosenvinge FS; Knudsen JD; Lemming L; Schønheyder HC; Hare RK; Kristensen L; Nielsen L; Gertsen JB; Dzajic E; Pedersen M; Østergård C; Olesen B; Søndergaard TS; Arendrup MC
    J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29212705
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Candida auris in Healthcare Facilities, New York, USA, 2013-2017.
    Adams E; Quinn M; Tsay S; Poirot E; Chaturvedi S; Southwick K; Greenko J; Fernandez R; Kallen A; Vallabhaneni S; Haley V; Hutton B; Blog D; Lutterloh E; Zucker H;
    Emerg Infect Dis; 2018 Oct; 24(10):1816-1824. PubMed ID: 30226155
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activity of CD101, a long-acting echinocandin, against clinical isolates of Candida auris.
    Berkow EL; Lockhart SR
    Diagn Microbiol Infect Dis; 2018 Mar; 90(3):196-197. PubMed ID: 29307565
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is the superbug fungus really so scary? A systematic review and meta-analysis of global epidemiology and mortality of Candida auris.
    Chen J; Tian S; Han X; Chu Y; Wang Q; Zhou B; Shang H
    BMC Infect Dis; 2020 Nov; 20(1):827. PubMed ID: 33176724
    [TBL] [Abstract][Full Text] [Related]  

  • 46.
    Hager CL; Larkin EL; Long L; Zohra Abidi F; Shaw KJ; Ghannoum MA
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311065
    [No Abstract]   [Full Text] [Related]  

  • 47. Candida auris and Nosocomial Infection.
    Dahiya S; Chhillar AK; Sharma N; Choudhary P; Punia A; Balhara M; Kaushik K; Parmar VS
    Curr Drug Targets; 2020; 21(4):365-373. PubMed ID: 31549952
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fluconazole-Resistant Candida parapsilosis Bloodstream Isolates with Y132F Mutation in ERG11 Gene, South Korea.
    Choi YJ; Kim YJ; Yong D; Byun JH; Kim TS; Chang YS; Choi MJ; Byeon SA; Won EJ; Kim SH; Shin MG; Shin JH
    Emerg Infect Dis; 2018 Sep; 24(9):1768-1770. PubMed ID: 30124412
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Persistent candidemia despite appropriate fungal therapy: First case of Candida auris from the United Arab Emirates.
    Alatoom A; Sartawi M; Lawlor K; AbdelWareth L; Thomsen J; Nusair A; Mirza I
    Int J Infect Dis; 2018 May; 70():36-37. PubMed ID: 29452247
    [TBL] [Abstract][Full Text] [Related]  

  • 50.
    Warris A
    Arch Dis Child; 2018 Sep; 103(9):891-894. PubMed ID: 29545411
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multi-drug resistant oral Candida species isolated from HIV-positive patients in South Africa and Cameroon.
    Dos Santos Abrantes PM; McArthur CP; Africa CW
    Diagn Microbiol Infect Dis; 2014 Jun; 79(2):222-7. PubMed ID: 24726686
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Candida auris-the growing menace to global health.
    Lone SA; Ahmad A
    Mycoses; 2019 Aug; 62(8):620-637. PubMed ID: 30773703
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment.
    Arendrup MC; Patterson TF
    J Infect Dis; 2017 Aug; 216(suppl_3):S445-S451. PubMed ID: 28911043
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular characterisation and clinical outcomes of Candida auris infection: Single-centre experience in Saudi Arabia.
    Almaghrabi RS; Albalawi R; Mutabagani M; Atienza E; Aljumaah S; Gade L; Forsberg K; Litvintseva A; Althawadi S
    Mycoses; 2020 May; 63(5):452-460. PubMed ID: 32072717
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combined Antifungal Resistance and Biofilm Tolerance: the Global Threat of Candida auris.
    Kean R; Ramage G
    mSphere; 2019 Jul; 4(4):. PubMed ID: 31366705
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Candida auris Sternal Osteomyelitis in a Man from Kenya Visiting Australia, 2015.
    Heath CH; Dyer JR; Pang S; Coombs GW; Gardam DJ
    Emerg Infect Dis; 2019 Jan; 25(1):192-194. PubMed ID: 30561310
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thinking beyond the Common Candida Species: Need for Species-Level Identification of Candida Due to the Emergence of Multidrug-Resistant Candida auris.
    Lockhart SR; Jackson BR; Vallabhaneni S; Ostrosky-Zeichner L; Pappas PG; Chiller T
    J Clin Microbiol; 2017 Dec; 55(12):3324-3327. PubMed ID: 28904185
    [No Abstract]   [Full Text] [Related]  

  • 58. Acquired echinocandin resistance in a Candida krusei blood isolate confirmed by mutations in the fks1 gene.
    Prigitano A; Esposito MC; Cogliati M; Pitzurra L; Santamaria C; Tortorano AM
    New Microbiol; 2014 Apr; 37(2):237-40. PubMed ID: 24858652
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical profile, antifungal susceptibility, and molecular characterization of Candida auris isolated from patients in a South Indian surgical ICU.
    Umamaheshwari S; Neelambike SM; Shankarnarayan SA; Kumarswamy KS; Gopal S; Prakash H; Rudramurthy SM
    J Mycol Med; 2021 Dec; 31(4):101176. PubMed ID: 34340186
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparing the virulence of four major clades of Candida auris strains using a silkworm infection model: Clade IV isolates had higher virulence than the other clades.
    Kurakado S; Matsumoto Y; Sugita T
    Med Mycol; 2023 Nov; 61(11):. PubMed ID: 37898558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.